Delivery Order SPE2DB20D2001-SPE2DB22FM70L
Award Date
8/26/22
Potential Completion Date
8/29/22
Potential Value
$107K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $10,832.61, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Uroxatral 10 mg tablets. The award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $33,169.94 Firm Fixed Price Delivery Order contract covers the supply of 4562815931 UROXATRAL 10 MG TABLET 100S, a pharmaceutical product, with a period of performance through November 15, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office division, a major pharmaceutical distributor. The $3,381.44 firm fixed price delivery order contract is for the supply of 100 tablets of the prescription drug Uroxatral 10 mg. The contract has an ultimate completion date of August 13, 2024. This award is a part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $79,023.53 firm fixed-price delivery order is for the supply of Uroxatral 10 mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Uroxatral 10 mg tablets. The $9,582.62 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen's parent company, Cencora, Inc., and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for...
This federal contract award, valued at $35,120.21, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order contract for the supply of UROXATRAL 10 MG TABLET 100S, with an ultimate completion date of October 13, 2023. The contract is a Firm Fixed Price agreement, without any set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $51,991.28 firm-fixed-price delivery order is for the supply of UROXATRAL 10 MG TABLET 100S, a medication used to treat symptoms of an enlarged prostate. The contract has a period of performance through June 6, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award, valued at $11,796.81, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award is for the delivery of UROXATRAL 10 MG TABLET 100S, a pharmaceutical product. The contract has a completion date of February 13, 2024 and is a firm-fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (DO) with a ceiling value of $45,529.89. The contract is for the supply of 4561307353 - UROXATRAL 10 MG TABLET 100S, a pharmaceutical product, and was awarded by the Defense Logistics Agency (DLA), a defense agency. The award has a completion date of June 21, 2023 and was issued on June 20, 2023. There was no set-aside designation for this contract. Amerisourcebergen Drug Corp holds a...
This federal contract award, valued at $32,656.54, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the procurement of 4,563,742,508 units of Uroxatral 10 mg tablets. This award is not designated under any set-aside program. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has established itself as a key vendor for federal healthcare programs, particularly within the...